Edgestream Partners, L.P.

Position in INCY — Incyte Corp

CIK 1535061 Princeton, NJ

Position in INCY

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$14,821,264

+$13,724,424 QoQ

Shares Held

157,472

+1318.0% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Edgestream Partners, L.P. holds $88,282,973 across 25 Biotechnology names. INCY ranks #1 (16.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp This page	157,472	$14,821,264
2	EXEL	Exelixis, Inc.	174,455	$7,482,374
3	RVMD	Revolution Medicines, Inc.	69,262	$6,735,729
4	ARWR	Arrowhead Pharmaceuticals, Inc.	91,997	$5,768,211
5	TGTX	Tg Therapeutics, Inc.	168,351	$5,592,620
6	IONS	Ionis Pharmaceuticals Inc	68,369	$5,133,828
7	AGIO	Agios Pharmaceuticals, Inc.	143,731	$4,862,419
8	ACAD	Acadia Pharmaceuticals Inc	191,328	$4,258,961

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,821,264	157,472	+1318.0%	Shares	Sole	2026-05-18
2025-12-31	$1,096,840	11,105	-81.8%	Shares	Sole	2026-02-13
2024-12-31	$4,225,288	61,174	+173.0%	Shares	Sole	2025-02-07
2024-09-30	$1,481,168	22,408	-47.6%	Shares	Sole	2024-11-14
2024-03-31	$2,436,948	42,776	+1197.0%	Shares	Sole	2024-05-10
2023-12-31	$207,081	3,298	-94.3%	Shares	Sole	2024-02-14
2023-09-30	$3,324,663	57,550	+209.8%	Shares	Sole	2023-11-15
2023-06-30	$1,156,480	18,578	-11.8%	Shares	Sole	2023-08-10
2023-03-31	$1,522,078	21,061	-56.1%	Shares	Sole	2023-05-15
2022-06-30	$3,644,964	47,979	-26.3%	Shares	Sole	2022-08-12
2022-03-31	$5,172,068	65,123	+1069.4%	Shares	Sole	2022-05-13
2021-06-30	$468,519	5,569	—	Shares	Sole	2021-08-10
No filing history on record for this holder in this stock.